SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-082624
Filing Date
2021-06-17
Accepted
2021-06-17 16:21:07
Documents
13
Period of Report
2021-06-14
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2120035d1_8k.htm   iXBRL 8-K 28981
  Complete submission text file 0001104659-21-082624.txt   250687

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA fbio-20210614.xsd EX-101.SCH 3767
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE fbio-20210614_def.xml EX-101.DEF 27400
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE fbio-20210614_lab.xml EX-101.LAB 37127
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fbio-20210614_pre.xml EX-101.PRE 26025
6 EXTRACTED XBRL INSTANCE DOCUMENT tm2120035d1_8k_htm.xml XML 5449
Mailing Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014 781-652-4500
Fortress Biotech, Inc. (Filer) CIK: 0001429260 (see all company filings)

IRS No.: 205157386 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35366 | Film No.: 211025019
SIC: 2834 Pharmaceutical Preparations